|
Array BioPharma scores midstage success for asthma drug
FierceBiotech Array BioPharma has another asset on deck for a potential partnership. The Boulder, CO-based drug developer has touted upbeat Phase II data for an experimental drug in patients with allergic asthma, and the company ($ARRY) plans to seek a partner to … Array asthma drug meets main goal in mid-stage study Array BioPharma: Study Shows Asthma Candidate ARRY-502 Improves Lung … Array Seeks Asthma Drug Partner Following Mid-Stage Study Results |
View full post on asthma – Google News